A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species

References

• Aaron R K, Boyan B D, Ciombor D M, Schwartz Z, Simon B J. Stimulation of growth factor synthesis by electric and magnetic fields. Clinical Orthopedics and Related Research 2004; 419: 30–37
   PubMed Web of Science ®Google Scholar
• Ahlbom I C, Cardis E, Green A, Linet M, Savitz D, Swerdlow A. Review of the epidemiologic literature on MF and Health. Environmental Health Perspectives 2001; 109(Suppl. 6)911–933
   PubMed Web of Science ®Google Scholar
• Blagosklonny M V. Mitotic arrest and cell fate: Why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 2007; 6: 70–74
   PubMed Web of Science ®Google Scholar
• Charles L E, Loomis D, Shy C M, Newman B, Millikan R, Nylander-French L A, Couper D. Magnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. American Journal of Epidemiology 2003; 157: 683–691
   PubMed Web of Science ®Google Scholar
• Connolly J M, Rose D P. Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 1991; 19: 173–180
   PubMedGoogle Scholar
• Connolly J M, Rose D P. Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate 1994; 24: 167–175
   PubMed Web of Science ®Google Scholar
• Ding G R, Nakahara T, Hirose H, Koyama S, Takashima Y, Miyakoshi J. Extremely low frequency magnetic fields and the promotion of H2O2-induced cell death in HL-60 cells. International Journal of Radiation Biology 2004; 80: 317–324
   PubMed Web of Science ®Google Scholar
• Ding G R, Nakahara T, Tian F R, Guo Y, Miyakoshi J. Transient suppression of X-ray-induced apoptosis by exposure to power frequency magnetic fields in MCF-7 cells. Biochemical and Biophysical Research Communication 2001; 286: 953–957
   PubMed Web of Science ®Google Scholar
• Elliott R L, Blobe G C. Role of transforming growth factor Beta in human cancer. Journal of Clinical Oncology 2005; 23: 2078–2093
   PubMed Web of Science ®Google Scholar
• Frahm J, Lantow M, Lupke M, Weiss D G, Simko M. Alteration in cellular functions in mouse macrophages after exposure to 50 Hz magnetic fields. Journal of Cellular Biochemistry 2006; 99: 168–177
   PubMed Web of Science ®Google Scholar
• Guo J, Zhu T, Xiao Z X, Chen C Y. Modulation of intracellular signaling pathways to induce apoptosis in prostate cancer cells. Journal of Biological Chemistry 2007; 282: 24364–24372
   PubMedGoogle Scholar
• Hofer D R, Sherwood E R, Bromberg W D, Mendelsohn J, Lee C, Kozlowski J M. Autonomous growth of androgen-independent human prostatic carcinoma cells: Role of transforming growth factor alpha. Cancer Research 1991; 51: 2780–2785
   PubMed Web of Science ®Google Scholar
• Knave B. Electric and magnetic fields and health outcomes – an overview. 1994. Scandinavian Journal of Work, Environment and Health 1994; 20(Spec No)78–89
   PubMedGoogle Scholar
• Kumar B, Koul S, Khandrika L, Meacham R B, Koul H K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Research 2008; 68: 1777–1785
   PubMed Web of Science ®Google Scholar
• Lantow M, Lupke M, Frahm J, Mattsson M O, Kuster N, Simko M. ROS release and Hsp70 expression after exposure to 1,800 MHz radiofrequency electromagnetic fields in primary human monocytes and lymphocytes. Radiation and Environmental Biophysics 2006; 45: 55–62
   PubMed Web of Science ®Google Scholar
• Li G x, Hu H, Jiang C, Schuster T, Lü J. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. International Journal of Cancer 2007; 120: 2034–2043
   PubMed Web of Science ®Google Scholar
• Lupke M, Rollwitz J, Simko M. Cell activating capacity of 50 Hz magnetic fields to release reactive oxygen intermediates in human umbilical cord blood-derived monocytes and in Mono Mac 6 cells. Free Radical Research 2004; 38: 985–993
   PubMed Web of Science ®Google Scholar
• Park J I, Lee M G, Cho K, Park B J, Chae K S, Byun D S, Ryu B K, Park Y K, Chi S G. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 2003; 22: 4314–4332
   PubMed Web of Science ®Google Scholar
• Pienta K J, Smith D C. Advances in prostate cancer chemotherapy: A new era begins. CA: A Cancer Journal for Clinicians 2005; 55: 300–318, quiz 323–305
   PubMedGoogle Scholar
• Repacholi M H, Greenebaum B. Interaction of static and extremely low frequency electric and magnetic fields with living systems: Health effects and research needs. Biomagnetics 1999; 20: 133–160
   Google Scholar
• Riedl S J, Salvesen G S. The apoptosome: Signalling platform of cell death. Nature Reviews Molecular Cell Biology 2007; 8: 405–413
   PubMed Web of Science ®Google Scholar
• Santini M T, Ferrante A, Rainaldi G, Indovina P, Indovina P L. Extremely low frequency (ELF) magnetic fields and apoptosis: A review. International Journal of Radiation Biology 2005; 81: 1–11
   PubMed Web of Science ®Google Scholar
• Savitz D A, Loomis D P. Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. American Journal of Epidemiology 1995; 141: 123–134
   PubMed Web of Science ®Google Scholar
• Singh S V, Srivastava S K, Choi S, Lew K L, Antosiewicz J, Xiao D, Zeng Y, Watkins S C, Johnson C S, Trump D L, Lee Y J, Xiao H, Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. Journal of Biological Chemistry 2005; 280: 19911–19924
   PubMed Web of Science ®Google Scholar
• Theriault G, Goldberg M, Miller A B, Armstrong B, Guenel P, Deadman J, Imbernon E, To T, Chevalier A, Cyr D, et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970–1989. American Journal of Epidemiology 1994; 139: 550–572
   PubMed Web of Science ®Google Scholar
• Tornqvist S, Norell S, Ahlbom A, Knave B. Cancer in the electric power industry. British Journal of Industrial Medicine 1986; 43: 212–213
   PubMedGoogle Scholar
• Tynes T, Andersen A, Langmark F. Incidence of cancer in Norwegian workers potentially exposed to magnetic fields. American Journal of Epidemiology 1992; 136: 81–88
   PubMed Web of Science ®Google Scholar
• van der Poel H G. Smart drugs in prostate cancer. European Urology 2004; 45: 1–17
   PubMedGoogle Scholar
• Watson J M, Parrish E A, Rinehart C A. Selective potentiation of gynecologic cancer cell growth in vitro by magnetic fields. Gynecologic Oncology 1998; 71: 64–71
   PubMed Web of Science ®Google Scholar
• Wei M, Guizzetti M, Yost M, Costa L G. Exposure to 60-Hz magnetic fields and proliferation of human astrocytoma cells in vitro. Toxicology and Applied Pharmacology 2000; 162: 166–176
   PubMed Web of Science ®Google Scholar